BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37381752)

  • 1. Clonal hematopoiesis with
    Stelmach P; Richter S; Sauer S; Fabre MA; Gu M; Rohde C; Janssen M; Liebers N; Proynova R; Weinhold N; Raab MS; Goldschmidt H; Besenbeck B; Pavel P; Laier S; Trumpp A; Dietrich S; Vassiliou GS; Müller-Tidow C
    Haematologica; 2023 Dec; 108(12):3308-3320. PubMed ID: 37381752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.
    Gramegna D; Bertoli D; Cattaneo C; Almici C; Re A; Belotti A; Borlenghi E; Lanzi G; Archetti S; Verardi R; Brugnoni D; Sciumè M; Daffini R; Roccaro AM; Tucci A; Rossi G
    Ann Hematol; 2022 Jun; 101(6):1227-1237. PubMed ID: 35380239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal hematopoiesis in hematopoietic stem cell transplantation.
    Wilk CM; Manz MG; Boettcher S
    Curr Opin Hematol; 2021 Mar; 28(2):94-100. PubMed ID: 33394723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy.
    Hsu JI; Dayaram T; Tovy A; De Braekeleer E; Jeong M; Wang F; Zhang J; Heffernan TP; Gera S; Kovacs JJ; Marszalek JR; Bristow C; Yan Y; Garcia-Manero G; Kantarjian H; Vassiliou G; Futreal PA; Donehower LA; Takahashi K; Goodell MA
    Cell Stem Cell; 2018 Nov; 23(5):700-713.e6. PubMed ID: 30388424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma.
    Lackraj T; Ben Barouch S; Medeiros JJF; Pedersen S; Danesh A; Bakhtiari M; Hong M; Tong K; Joynt J; Arruda A; Minden MD; Kuruvilla J; Bhella S; Kukreti V; Crump M; Prica A; Chen C; Deng Y; Xu W; Pugh TJ; Keating A; Dick JE; Abelson S; Kridel R
    Am J Hematol; 2022 Dec; 97(12):1538-1547. PubMed ID: 36087071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation.
    Soerensen JF; Aggerholm A; Rosenberg CA; Bill M; Kerndrup GB; Ebbesen LH; Hansen MH; Roug AS; Ludvigsen M
    Bone Marrow Transplant; 2022 Mar; 57(3):460-465. PubMed ID: 35027675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation.
    Gibson CJ; Kim HT; Zhao L; Murdock HM; Hambley B; Ogata A; Madero-Marroquin R; Wang S; Green L; Fleharty M; Dougan T; Cheng CA; Blumenstiel B; Cibulskis C; Tsuji J; Duran M; Gocke CD; Antin JH; Nikiforow S; DeZern AE; Chen YB; Ho VT; Jones RJ; Lennon NJ; Walt DR; Ritz J; Soiffer RJ; Gondek LP; Lindsley RC
    J Clin Oncol; 2022 Jan; 40(2):189-201. PubMed ID: 34793200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma.
    Gibson CJ; Lindsley RC; Tchekmedyian V; Mar BG; Shi J; Jaiswal S; Bosworth A; Francisco L; He J; Bansal A; Morgan EA; Lacasce AS; Freedman AS; Fisher DC; Jacobsen E; Armand P; Alyea EP; Koreth J; Ho V; Soiffer RJ; Antin JH; Ritz J; Nikiforow S; Forman SJ; Michor F; Neuberg D; Bhatia R; Bhatia S; Ebert BL
    J Clin Oncol; 2017 May; 35(14):1598-1605. PubMed ID: 28068180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Dominance of CHIP-Mutated Hematopoietic Stem Cells in Patients Undergoing Autologous Transplantation.
    Ortmann CA; Dorsheimer L; Abou-El-Ardat K; Hoffrichter J; Assmus B; Bonig H; Scholz A; Pfeifer H; Martin H; Schmid T; Brüne B; Scheich S; Steffen B; Riemann J; Hermann S; Dukat A; Bug G; Brandts CH; Wagner S; Serve H; Rieger MA
    Cell Rep; 2019 May; 27(7):2022-2028.e3. PubMed ID: 31091442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse.
    Newell LF; Williams T; Liu J; Yu Y; Chen Y; Booth GC; Knight RJ; Goslee KR; Cook RJ; Leonard J; Meyers G; Traer E; Press RD; Fan G; Wang Y; Raess PW; Maziarz RT; Dunlap J
    Transplant Cell Ther; 2021 Aug; 27(8):662.e1-662.e9. PubMed ID: 33901720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical implications of clonal hematopoiesis in hematopoietic cell transplantation.
    Nawas MT; Schetelig J; Damm F; Levine RL; Perales MA; Giralt SA; VanDenBrink MR; Arcila ME; Zehir A; Papaemmanuil E; Klussmeier A; Schmidt AH; Maiwald S; Bolton KL; Tamari R
    Blood Rev; 2021 Mar; 46():100744. PubMed ID: 32896435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant
    Singh A; Mencia-Trinchant N; Griffiths EA; Altahan A; Swaminathan M; Gupta M; Gravina M; Tajammal R; Faber MG; Yan L; Sinha E; Hassane DC; Hayes DN; Guzman ML; Iyer R; Wang ES; Thota S
    JCO Precis Oncol; 2022 Jan; 6():e2100309. PubMed ID: 35025619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant.
    Mouhieddine TH; Sperling AS; Redd R; Park J; Leventhal M; Gibson CJ; Manier S; Nassar AH; Capelletti M; Huynh D; Bustoros M; Sklavenitis-Pistofidis R; Tahri S; Hornburg K; Dumke H; Itani MM; Boehner CJ; Liu CJ; AlDubayan SH; Reardon B; Van Allen EM; Keats JJ; Stewart C; Mehr S; Auclair D; Schlossman RL; Munshi NC; Anderson KC; Steensma DP; Laubach JP; Richardson PG; Ritz J; Ebert BL; Soiffer RJ; Trippa L; Getz G; Neuberg DS; Ghobrial IM
    Nat Commun; 2020 Jun; 11(1):2996. PubMed ID: 32533060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly.
    Zink F; Stacey SN; Norddahl GL; Frigge ML; Magnusson OT; Jonsdottir I; Thorgeirsson TE; Sigurdsson A; Gudjonsson SA; Gudmundsson J; Jonasson JG; Tryggvadottir L; Jonsson T; Helgason A; Gylfason A; Sulem P; Rafnar T; Thorsteinsdottir U; Gudbjartsson DF; Masson G; Kong A; Stefansson K
    Blood; 2017 Aug; 130(6):742-752. PubMed ID: 28483762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple Myeloma.
    Mouhieddine TH; Nzerem C; Redd R; Dunford A; Leventhal M; Sklavenitis-Pistofidis R; Tahri S; El-Khoury H; Steensma DP; Ebert BL; Soiffer RJ; Keats JJ; Mehr S; Auclair D; Ghobrial IM; Sperling AS; Stewart C; Getz G
    Cancer Res Commun; 2023 Dec; 3(12):2560-2571. PubMed ID: 38019104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The crossroads of cancer therapies and clonal hematopoiesis.
    Singh A; Balasubramanian S
    Semin Hematol; 2024 Feb; 61(1):16-21. PubMed ID: 38403501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal hematopoiesis in the setting of hematopoietic cell transplantation.
    Gibson CJ; Lindsley RC; Gondek LP
    Semin Hematol; 2024 Feb; 61(1):9-15. PubMed ID: 38429201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients.
    Borsi E; Vigliotta I; Poletti A; Mazzocchetti G; Solli V; Zazzeroni L; Martello M; Armuzzi S; Taurisano B; Kanapari A; Pistis I; Zamagni E; Pantani L; Rocchi S; Mancuso K; Tacchetti P; Rizzello I; Rizzi S; Dan E; Sinigaglia B; Cavo M; Terragna C
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dnmt3a-null hematopoietic stem and progenitor cells expand after busulfan treatment.
    Chen J; Matatall KA; Feng X; Hormaechea-Agulla D; Maharjan M; Young N; King KY
    Exp Hematol; 2020 Nov; 91():39-45.e2. PubMed ID: 32961298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental influences on clonal hematopoiesis.
    King KY; Huang Y; Nakada D; Goodell MA
    Exp Hematol; 2020 Mar; 83():66-73. PubMed ID: 31893524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.